Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

83.28
Delayed Data
As of Aug 23
 -0.23 / -0.28%
Today’s Change
66.93
Today|||52-Week Range
86.90
+14.33%
Year-to-Date
Why Have Mylan's (MYL) Shares Lost 19.4% So Far This Year?
Aug 23 / Zacks.com - Paid Partner Content
Can Pfizer Bank on New Immunotherapy Bavencio for Growth?
Aug 17 / Zacks.com - Paid Partner Content
Are Glaxo's Successful New Drugs Enough to Drive Growth?
Aug 23 / Zacks.com - Paid Partner Content
Ophthotech's Fovista Combo Regimen Disappoints in Phase III
Aug 16 / Zacks.com - Paid Partner Content
4 Biotech Stocks to Add to your Portfolio Post Q2 Earnings
Aug 22 / Zacks.com - Paid Partner Content
Catalyst (CPRX) Focused on Development of Pipeline Candidates
Aug 15 / Zacks.com - Paid Partner Content
Biogen & 6 Other Multiple Sclerosis Drug Stocks in Focus: Here's Why
Aug 21 / Zacks.com - Paid Partner Content
Can Ligand's Captisol Deals Boost Growth in the Long Run?
Aug 15 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Multiple Sclerosis Drug Prices in Focus, Mixed Data on BMY's Op...
Aug 18 / Zacks.com - Paid Partner Content
Are Amgen's New Drugs Doing Well Enough to Drive Sales?
Aug 15 / Zacks.com - Paid Partner Content
European Pharma Companies Slip on MS Pricing Probe
Aug 18 / TheStreet.com - Paid Partner Content
The Medicines Company (MDCO) Q2 Loss Widens, Revenues Miss
Aug 10 / Zacks.com - Paid Partner Content